A 55-year-old female, with primary splenic angiosarcoma with metastatic lesions in liver, T-8 vertebra and left femur, status postsplenectomy, right hepatectomy and cholecystectomy, and multiple cycles of chemotherapy, was found to have a new 0.5 cm ill-defined attenuation focus in the body of pancreas on routine surveillance computed tomography (CT) scan. Follow-up of CT 2 months later revealed increase in size of the same mass to 0.8 cm \[[Figure 1](#F1){ref-type="fig"}\], worrisome of progressive metastatic lesion from angiosarcoma. The patient was referred for endoscopic ultrasound (EUS)-guided fine-needle aspiration and biopsy (FNAB). On EUS \[[Figure 2](#F2){ref-type="fig"}\], an 8 mm × 6 mm isoechoic rounded mass was seen in the pancreatic body. Transgastric EUS-guided fine-needle aspiration (two passes) and fine-needle core biopsy (two passes) were done using a 25 G, ProCore EUS needle (Cook). On cytology, specimens along with immunostains performed on the cell block sections showed that the neoplastic cells were positive for ERG and CD31 and focally/weakly positive for pan-cytokeratin. Immunohistochemical staining of the core biopsy revealed that the tumor cells were strongly positive for ERG (nuclear pattern), focally positive for CD31 and CD34, and negative for synaptophysin and chromogranin. This was consistent with metastatic angiosarcoma \[Figures [3](#F3){ref-type="fig"}--[6](#F6){ref-type="fig"}\].

![Computed tomography scan showing (arrow) a small, 8 mm, subtle, ill-defined mass in the pancreatic body](EUS-6-340-g001){#F1}

![Endoscopic ultrasound exam revealing the same lesion (arrows) that was subjected to endoscopic ultrasound-guided fine-needle aspiration and core biopsy](EUS-6-340-g002){#F2}

![Papanicolaou-stained smear shows a group of spindled to epithelioid cells with coarse chromatin pattern consistent with the patient\'s history of angiosarcoma](EUS-6-340-g003){#F3}

![H and E stain of a cell block preparation demonstrates a small of groups of neoplastic spindle cells](EUS-6-340-g004){#F4}

![Immunohistochemistry performed on the cell block preparation shows positive staining for CD31, consistent with angiosarcoma](EUS-6-340-g005){#F5}

![Immunohistochemistry performed on the cell block preparation shows positive staining for ERG, consistent with angiosarcoma](EUS-6-340-g006){#F6}

Angiosarcomas are rare, malignant, and frequently fatal soft tissue tumors and may metastasize to almost all visceral organs including pancreas. Definitive diagnosis can be made only with immunochemistry, and hence, obtaining biopsy is of paramount importance. EUS-FNAB has previously been described for diagnosing angiosarcoma in suprarenal gland\[[@ref1]\] and spleen\[[@ref2]\] in two prior case reports. To our knowledge, we present the first case of EUS-FNAB use for diagnosis of angiosarcoma within the pancreas. Primary angiosarcoma in pancreas may present as acute pancreatitis and diagnosis may be missed if biopsy is not performed as described by Csiszkó *et al*.\[[@ref3]\] and Seth *et al*.\[[@ref4]\] separately in their case reports. We recommend keeping angiosarcoma as a possible rare differential while evaluating pancreatic masses and using EUS-guided FNAB with these well-evaluated core needles\[[@ref5][@ref6]\] to confirm the diagnosis.
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